IMM 3.57% 2.7¢ immutep limited

https://clinicaltrials.gov/ct2/show/NCT03499899 A Study of...

  1. 396 Posts.
    lightbulb Created with Sketch. 8
    https://clinicaltrials.gov/ct2/show/NCT03499899



    A Study of Efficacy and Safety of LAG525 in Combination With Spartalizumab, or With Spartalizumab and Carboplatin, or With Carboplatin, in Patients With Advanced Triple-negative Breast Cancer


    Column 1 Column 2
    0 Estimated Study Start Date : June 20, 2018
    1 Estimated Primary Completion Date : September 30, 2019
    2 Estimated Study Completion Date : October 12, 2020


    Glta
    Fishywoo
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
-0.001(3.57%)
Mkt cap ! $104.6M
Open High Low Value Volume
2.8¢ 2.9¢ 2.7¢ $462.8K 16.43M

Buyers (Bids)

No. Vol. Price($)
13 8660689 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 2865641 5
View Market Depth
Last trade - 16.10pm 17/10/2019 (20 minute delay) ?
(live)
Last
2.7¢
  Change
-0.001 ( 0.00 %)
Open High Low Volume
2.8¢ 3.0¢ 2.7¢ 4275622
Last updated 15.59pm 17/10/2019 (live) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.